Enhanced plasma performance in C-2W advanced beam-driven field-reversed configuration experiments

Autor: H. Gota, A. Smirnov, M.W. Binderbauer, T. Tajima, S. Putvinski, J.B. Titus, M. Nations, T. Roche, E. Trask, T. DeHaas, S.A. Dettrick, E.M. Granstedt, D.K. Gupta, S. Gupta, A.A. Ivanov, S. Korepanov, R.M. Magee, T. Matsumoto, J.A. Romero, P. Yushmanov, K. Zhai, L. Schmitz, Z. Lin, S. Krasheninnikov, E.A. Baltz, J.C. Platt, E.V. Belova, T. Asai, A.I. Smolyakov, S. Abdollahi, S. Abramov, A. Alexander, I. Allfrey, R. Andow, D.C. Barnes, B. Barnett, J. Barrett, M. Beall, N.G. Bolte, E. Bomgardner, A. Bondarenko, F. Brighenti, J. Buttery, S. Caton, F. Ceccherini, Y. Choi, R. Clary, A. Cooper, C. Deng, A. de Vera, J. Drobny, A. Dunaevsky, C. Exton, A. Fareed, P. Feng, C. Finucane, D. Fluegge, A. Fontanilla, Y. Fujiwara, L. Galeotti, S. Galkin, R. Groenewald, T. Hsyu, K. Hubbard, R. Jaber, L. Jian, N. Kafle, S. Kamio, S. Karbashewski, J.S. Kinley, A. Korepanov, G. Koumarianou, S. Krause, P. Kudrin, C.K. Lau, H. Leinweber, J. Leuenberger, D. Lieurance, M. Litton, R. Luna, R. Luong, J. MacFarlane, D. Madura, J. Margo, D. Marshall, V. Matvienko, M. Meekins, W. Melian, R. Mendoza, R. Michel, M. Morehouse, Y. Musthafa, S. Nazarenko, A. Necas, B.S. Nicks, N. Nwoke, S. Ohshima, M. Onofri, R. Page, J. Park, E. Parke, S. Patel, L. Pennings, K. Phung, G. Player, L. Rios, I. Sato, J.H. Schroeder, Y. Shimabukuro, M. Showers, A. Sibley, M. Signorelli, M. Slepchenkov, R.J. Smith, G. Snitchler, V. Sokolov, D. Solyakov, Y. Song, B. Sporer, L.C. Steinhauer, C. Stonier, A. Stratta, J. Sweeney, M. Tobin, M. Tuszewski, J. Ufnal, T. Valentine, S. Vargas, A.D. Van Drie, V. Vekselman, A. Veksler, C. Weixel, C. White, M. Wollenberg, J. Wood, Y. Zhou, S. Ziaei, the TAE Team

Publikováno v: Nuclear Fusion, Vol 64, Iss 11, p 112014 (2024)

TAE Technologies’ fifth-generation fusion device, C-2W (also called ‘Norman’), is the world’s largest compact-toroid device and has made significant progress in field-reversed configuration (FRC) plasma performance. C-2W produces record break

Externí odkaz: https://doaj.org/article/256b81cac41043c1a97676b160e67300

An observational study to assess the molecular epidemiology and direct medical costs of epidermal growth factor receptor (Egfr) mutations in patients with advanced egfr mutation-positive non-small cell lung cancer treated with afatinib in real-world clinical settings in Greece

Autor: Mountzios, G. Lampaki, S. Koliou, G.-A. Vozikis, A. Kontogiorgos, I. Papantoniou, P. Koufaki, M.I. Res, E. Boutis, A. Christopoulou, A. Pastelli, N. Grivas, A. Aravantinos, G. Lalla, E. Oikonomopoulos, G. Koumarianou, A. Spyratos, D. Bafaloukos, D., Snr Rigakos, G. Papakotoulas, P. Fountzilas, G. Linardou, H.

Purpose: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred first-line option for patients with advanced, EGFR-mutant non-small cell lung cancer (NSCLC). Afatinib, a second-generation irreversible EGFR-TKI, ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::8d1170e1561e5624975a5832e29d2e7b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103031

Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms

Autor: Daskalakis, K. Tsoli, M. Angelousi, A. Kassi, E. Alexandraki, K.I. Kolomodi, D. Kaltsas, G. Koumarianou, A.

Comparisons between everolimus and sunitinib regarding their efficacy and safety in neuroendocrine neoplasms (NENs) are scarce. We retrospectively analysed the clinicopathological characteristics and outcomes in 92 patients with well-differentiated (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::96cdebcdcb0570d39e1e5ff0bf62ce9e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078450

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Forming a Stress Management and Health Promotion Program for Women Undergoing Chemotherapy for Breast Cancer: A Pilot Randomized Controlled Trial

Autor: Pelekasis, P. Zisi, G. Koumarianou, A. Marioli, A. Chrousos, G. Syrigos, K. Darviri, C.

Objective. To assess the effects of an 8-week stress management and health promotion program on women undergoing breast cancer chemotherapy treatment. Patients and methods. A total of 61 patients were recruited in 2 cancer centers and were randomly a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::847858dcccb1d3bb2dc4907a6a5fbae4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101096